Diosgenin
Compiled from published pharmacological and botanical literature. Not independently verified by Herbuno. Spotted an error or have a correction? Flag it below →
| Chemical Class | Steroidal sapogenin (spirostanol-type) |
| Molecular Formula / CAS | C₂₄H₄₂O₃ · CAS 512-04-9 |
| Primary Botanical Source(s) | Wild yam (Dioscorea villosa); also fenugreek (Trigonella foenum-graecum) |
| Plant Part | Root / tuber (wild yam); seed (fenugreek) |
| Typical Content | Wild yam is the classic commercial source, historically used as the starting material for industrial steroid synthesis |
| Solubility / Format | Lipophilic steroidal aglycone; available as standardised powders at multiple concentrations |
| Sourcing Status | Product-live — genuine match via Herbuno’s wild yam-derived diosgenin extract line |
| Buy from Herbuno | Diosgenin 95% Powder (Wild Yam) · Diosgenin 16% Powder (Wild Yam Extract) |
Name origin: Diosgenin takes its name from the genus Dioscorea, the wild yams from which it was first isolated and characterised, itself named for the ancient Greek physician and botanist Pedanius Dioscorides. Traditional use: Wild yam has been used in traditional Central American, Mexican and Chinese herbal medicine for digestive and women’s health applications, though its most consequential historical role came in the 20th century as the raw material Russell Marker used to pioneer commercial steroid synthesis, launching the modern pharmaceutical steroid industry including the original combined oral contraceptive pill. Research trajectory: Diosgenin research began as industrial process chemistry — optimising its extraction and semi-synthetic conversion to cortisone, progesterone and other steroid hormones — and has since expanded into direct pharmacological investigation of diosgenin itself, particularly its anticancer, hypolipidemic and antioxidant activity independent of its role as a steroid precursor. Commercial source: Wild yam remains the classic and still-dominant commercial source of diosgenin, and Herbuno’s standardised extracts reflect this established, genuine botanical match.
Evidence for Diosgenin Applications
Diosgenin is a steroidal sapogenin — the aglycone released when steroidal saponins are hydrolysed — and its structural resemblance to cholesterol and other steroid hormones is both the basis of its historical importance as a pharmaceutical precursor and a plausible mechanistic link to its own direct biological activity. Diosgenin dietary supplements are not themselves hormonally active in the human body; the multi-step chemical conversion required to produce actual steroid hormones from diosgenin does not occur through simple digestion or metabolism. Claim strength: Moderate.
In a hyperlipidemic rat model, diosgenin treatment improved lipid profiles — increasing lipoprotein lipase, hepatic lipase, and antioxidant enzyme activity while reducing total cholesterol, triglycerides and LDL cholesterol — and separately protected cultured human vascular endothelial cells from hydrogen-peroxide-induced apoptosis and oxidative damage (Chen et al. 2010). This combination of a whole-animal lipid-metabolism effect with a cell-culture mechanistic finding is a relatively well-rounded piece of preclinical evidence, though it remains animal and cell-culture based rather than confirmed in human trials. Claim strength: Moderate.
Diosgenin has been studied extensively for anticancer activity across multiple cell lines. In HepG2 human liver cancer cells, diosgenin induced apoptosis through reactive oxygen species generation and mitochondrial pathway activation, building on a broader body of research showing diosgenin-induced apoptosis in breast, colon, and other cancer cell lines through mechanisms including p53 activation, caspase-3 modulation, and cell cycle arrest (et al. 2012). This research remains confined to in-vitro cell culture models and has not progressed to human cancer trials. Claim strength: Emerging.
Diosgenin’s antidiabetic research draws partly from work on related steroidal sapogenins isolated from other Dioscorea species: a study of bitter yam (D. polygonoides) sapogenins, including diosgenin itself, found that dietary supplementation significantly reduced fasting blood glucose in streptozotocin-induced diabetic rats and altered intestinal amylase and ATPase activity relevant to glucose handling (Omoruyi et al. 2005). This cross-species sapogenin research supports a plausible class-level hypoglycaemic mechanism but has not been confirmed for diosgenin specifically in controlled human diabetes trials. Claim strength: Emerging.
Formulators should note that diosgenin is also present in fenugreek seed alongside 4-hydroxyisoleucine, and the two compounds are sometimes discussed together in fenugreek research despite acting through distinct mechanisms; a diosgenin sourcing specification should not be assumed to also deliver a meaningful 4-hydroxyisoleucine content unless the material is independently verified for both markers. Claim strength: Moderate.
Dosage & Formulator Specification
No universally standardised human clinical dosing range exists for isolated diosgenin as a dietary supplement ingredient; most human-relevant dosing precedent instead concerns whole wild yam root extract used traditionally, typically in the range of several hundred milligrams to a few grams daily of standardised extract, rather than the isolated compound tested at pharmacological doses in preclinical research.
Analytical quantification of diosgenin content is performed by HPLC, the standard method used across the Dioscorea and fenugreek industrial-extraction literature; formulators should request HPLC-verified diosgenin percentage rather than relying on total-saponin figures, since total saponin content does not reliably predict diosgenin aglycone yield after hydrolysis.
Diosgenin dietary supplements marketed with hormone-related claims deserve particular scrutiny: diosgenin itself is not converted to progesterone, estrogen, or other steroid hormones within the human body through normal digestion, and no regulatory body recognises wild yam or diosgenin supplements as a source of bioidentical hormones despite this claim appearing in some commercial marketing. Formulators should avoid implying direct hormonal conversion in any diosgenin-based product positioning.
Regulatory positioning for diosgenin follows established wild yam and fenugreek botanical-ingredient precedent; wild yam root has a long food and traditional-medicine use history with no diosgenin-specific regulatory limit. Formulators should note the historical significance of diosgenin as an industrial steroid-synthesis precursor is a separate pharmaceutical-manufacturing context, distinct from and not transferable to dietary supplement positioning.
Frequently Asked Questions — Diosgenin
No. Despite some commercial marketing suggesting otherwise, diosgenin is not converted into progesterone, estrogen, or other steroid hormones through normal human digestion or metabolism. The multi-step chemical conversion used industrially to produce steroid drugs from diosgenin requires laboratory synthesis, not digestion.
Diosgenin was the raw material Russell Marker used in the mid-20th century to pioneer commercial steroid hormone synthesis, a breakthrough that made possible the original combined oral contraceptive pill and launched the modern pharmaceutical steroid industry. This is an industrial chemistry legacy separate from its current dietary supplement use.
Laboratory cell-culture studies have found diosgenin induces apoptosis in several cancer cell lines, including liver, breast, and colon cancer cells, through mechanisms involving reactive oxygen species and mitochondrial pathways. This research remains at the cell-culture stage and has not been tested in human cancer trials.
No, they are two distinct compounds that both occur in fenugreek seed. Diosgenin is a steroidal sapogenin, while 4-hydroxyisoleucine is an unusual amino acid; they act through different mechanisms and a fenugreek extract standardised for one does not necessarily deliver meaningful levels of the other.
Related compounds: 4-Hydroxyisoleucine, Corosolic Acid